S-EPMC12351955 - Comparative efficacy of first- versus second-line CDK4/6 inhibition in hormone receptor-positive, HER2-negative metastatic breast cancer - OmicsDI

Unknown

Dataset Information

Comparative efficacy of first- versus second-line CDK4/6 inhibition in hormone receptor-positive, HER2-negative metastatic breast cancer

ABSTRACT:

SUBMITTER: Ravani L

PROVIDER: S-EPMC12351955 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature